Advertisement

Topics

Moderna/Merck cancer vaccine partnership raises $125m

11:23 EDT 4 May 2018 | Net Resources International

Moderna has gained $125 million in preferred equity for its messenger RNA (mRNA) cancer vaccine partnership with Merck, following on...
Read More...

The post Moderna/Merck cancer vaccine partnership raises $125m appeared first on Drug Development Technology.

Original Article: Moderna/Merck cancer vaccine partnership raises $125m

NEXT ARTICLE

More From BioPortfolio on "Moderna/Merck cancer vaccine partnership raises $125m"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...